Contributed Opinion
Stephen McBride (03/30/2026)
Stephen McBride of RiskHedge talks about his strategy for buying in a tumultuous world. Streetwise Reports (03/30/2026)
Uranium Energy Corp. (UEC:NYSE AMERICAN) restarts Wyoming mine, pursues conversion facility, and scales U.S. production assets amid domestic uranium shortage. Streetwise Reports (03/30/2026)
Contango ORE Inc (CTGO:NYSEA) and Dolly Varden Silver Corp. (DV:TSX.V; DVS:NYSEA; DVQ:FSE) successfully complete what one expert calls a transformative merger. Contributed Opinion
Michael Ballanger (03/30/2026)
Michael Ballanger of GGM Advisory Inc. shares his thoughts on the current state of the market, and shares one copper stock on his list. Streetwise Reports (03/30/2026)
Green Bridge Metals Corp. (GRBM:CSE; GBMCF:OTC; J48:FWB) reported visual sulphide mineralization across three initial drill holes at its Titac project in Minnesota. Streetwise Reports (03/30/2026)
B2Gold Corp. (BTG:NYSE; BTO:TSX; B2G:NSX) reported high-grade drill results and expanded resource potential from its 2025 Back River Gold District program. Research Report
Dr. Yun Zhong (03/27/2026)
Wedbush Securities raised its price target on Sarepta Therapeutics Inc. (SRPT:NASDAQ), following promising Phase 1/2 data for siRNA candidates SRP-1001 in FSHD and SRP-1003 in DM1, citing superior muscle concentration and a clean safety profile versus rival programs from Novartis and Dyne Therapeutics.